Skip to content

BioLife Solutions BLFS Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Danaher logo
DanaherDHR
Azenta logo
AzentaAZTA
Revvity logo
RevvityRVTY
Charles River Laboratories logo
Charles River LaboratoriesCRL
Labcorp Holdings logo
Labcorp HoldingsLH
International Flavors & Fragrances logo
International Flavors & FragrancesIFF

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
Enterprise value$1.24B+28.3%
P/S12.5×-0.4×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's common stock, shares, outstanding?
BioLife Solutions (BLFS) reported common stock, shares, outstanding of $48.83M in Q1 2026.
How has BioLife Solutions's common stock, shares, outstanding changed year-over-year?
BioLife Solutions's common stock, shares, outstanding increased by 2.7% year-over-year, from $47.55M to $48.83M.
What is the long-term trend for BioLife Solutions's common stock, shares, outstanding?
Over 3 years (2022 to 2025), BioLife Solutions's common stock, shares, outstanding has grown at a 4.0% compound annual growth rate (CAGR), from $42.83M to $48.2M.